We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study the Average Aerobic Bioburden Levels on Catheters After Use With Egret Catheter and the Predicate Device

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01124578
First Posted: May 17, 2010
Last Update Posted: October 12, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Egret Medical Products Inc.
  Purpose
PURPOSE OF EVALUATION: This study will verify & validate the acceptability of Egret's extended use product as compared to the existing daily change-out product. Based on an extensive in-vitro study, Egret's product confirmed significant kill for both positive and negative gram bacteria. In addition to meeting all of the current product requirements, total aerobic bio-burden on the catheters will be tested at various intervals for up to 10 days of use. The current used product will be used as a control group that is to be changed out daily as per current policy. The control group will be tested for total aerobic bacteria counts on the last day of use.

Condition
Suction Catheter Bioburder Level After Patient Use.

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Cross-Sectional
Official Title: Validate the Acceptability of Egret's Extended Use Product as Compared to the Existing Daily Change-out Product

Further study details as provided by Egret Medical Products Inc.:

Primary Outcome Measures:
  • Measure total aerobic bioburden levels after patient use [ Time Frame: 1 to 10 days ]
    Compare the average aerobic bio-burden level on the extended use Egret catheter to the existing used one day product after clinical use. The Egret catheter was used continuously for up to 10 days.


Secondary Outcome Measures:
  • No unexpected adverse events [ Time Frame: 1-10 days ]
    Verify that there were no unexpected adverse events associated with the Egret extended use catheter.

  • Design Ease of Use [ Time Frame: 1-10 days ]
    Obtain feedback from the respiratory care practitioners regarding comparative ease-of-use and design feature preferences between the Egret catheter and the Ballard catheter.


Enrollment: 200
Study Start Date: May 2008
Study Completion Date: March 2010
Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts
Control
Existing used daily change-out device
Egret
Extended Use Catheter w/BIOSAFE

  Show Detailed Description

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients admitted to Medical City who require ventilation
Criteria

Inclusion Criteria:

  • Patients who agree to consent.

Exclusion Criteria:

  • Patients who do not agree to consent or with confirmed Ventilator-associated Pneumonia (VAP)are to be excluded from this study.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01124578


Locations
United States, Texas
Medical City Dallas Hospital
Dallas, Texas, United States, 75230
Sponsors and Collaborators
Egret Medical Products Inc.
Investigators
Principal Investigator: David Barton, BA, RRT, RCP Medical City Hospital, Dallas, TX
  More Information

Publications:
1.Medical City Dallas Hospital, Policies and Procedures, Policy No. RSCC12 - Endotracheal Suctioning 2.MicroChem Labs - A Study to Measure the Total Aerobic Bacteria on Ballard Suction Catheters During 24 Hours Use with Respiratory Care Patients. This study was conducted to establish a baseline bio-burden count of catheter tips after use. 3.Nelson Laboratories - Bacterial Filtration Efficacy, Report No. 413451. This test was preformed to determine the bacterial filtration efficacy of the filter as per ASTM F2101. 4.Micro-Chem Labs - Evaluation of the Antimicrobial Properties of Sterilized and Non-Sterilized Egret Catheters Versus a Non-Treated Control Catheter During Extended Exposure to S. aureus, P. aeruginosa, and K. pneumoniae.

Responsible Party: David Barton, BA, RRT, RCP, Medical City Dallas Hospital
ClinicalTrials.gov Identifier: NCT01124578     History of Changes
Other Study ID Numbers: RT 2008-001
First Submitted: May 7, 2010
First Posted: May 17, 2010
Last Update Posted: October 12, 2017
Last Verified: May 2010

Keywords provided by Egret Medical Products Inc.:
Ventilators, Mechanical